Department of Integrative Physiology and Neuroscience, Washington State University-Spokane, WA, United States.
Department of Integrative Physiology and Neuroscience, Washington State University-Spokane, WA, United States.
Brain Behav Immun. 2021 May;94:245-258. doi: 10.1016/j.bbi.2021.01.036. Epub 2021 Feb 9.
Tumor necrosis factor alpha (TNF) has sleep regulatory and brain development roles. TNF promotes sleep in vivo and in vitro while TNF inhibition diminishes sleep. Transmembrane (tm) TNF and the tmTNF receptors (Rs), are cleaved by tumor necrosis factor alpha convertase to produce soluble (s) TNF and sTNFRs. Reverse signaling occurs in cells expressing tmTNF upon sTNFR binding. sTNFR administration in vivo inhibits sleep, thus we hypothesized that a wake-like state in vitro would be induced by sTNFR-tmTNF reverse signaling. Somatosensory cortical neuron/glia co-cultures derived from male and female mice lacking both TNFRs (TNFRKO), or lacking TNF (TNFKO) and wildtype (WT) mice were plated onto six-well multi-electrode arrays. Daily one-hour electrophysiological recordings were taken on culture days 4 through 14. sTNFR1 (0.0, 0.3, 3, 30, 60, and 120 ng/µL) was administered on day 14. A final one-hour recording was taken on day 15. Four measures were characterized that are also used to define sleep in vivo: action potentials (APs), burstiness index (BI), synchronization of electrical activity (SYN), and slow wave power (SWP; 0.25-3.75 Hz). Development rates of these emergent electrophysiological properties increased in cells from mice lacking TNF or both TNFRs compared to cells from WT mice. Decreased SWP, after the three lowest doses (0.3, 3 and 30 ng/µL) of the sTNFR1, indicate a wake-like state in cells from TNFRKO mice. A wake-like state was also induced after 3 ng/µl sTNFR1 treatment in cells from TNFKO mice, which express the TNFR1 ligand, lymphotoxin alpha. Cells from WT mice showed no treatment effects. Results are consistent with prior studies demonstrating involvement of TNF in brain development, TNF reverse signaling, and sleep regulation in vivo. Further, the current demonstration of sTNFR1 induction of a wake-like state in vitro is consistent with the idea that small neuronal/glial circuits manifest sleep- and wake-like states analogous to those occurring in vivo. Finally, that sTNF forward signaling enhances sleep while sTNFR1 reverse signaling enhances a wake-like state is consistent with other sTNF/tmTNF/sTNFR1 brain actions having opposing activities.
肿瘤坏死因子 α(TNF)在睡眠调节和大脑发育中发挥作用。TNF 在体内和体外促进睡眠,而 TNF 抑制则减少睡眠。跨膜(tm)TNF 和 tmTNF 受体(Rs)可被肿瘤坏死因子 α 转换酶切割,产生可溶性(s)TNF 和 sTNFRs。在表达 tmTNF 的细胞中发生反向信号转导,当 sTNFR 结合时。体内给予 sTNFR 可抑制睡眠,因此我们假设体外类似觉醒的状态会被 sTNFR-tmTNF 反向信号转导诱导。从缺乏两种 TNFR(TNFRKO)或缺乏 TNF(TNFKO)和野生型(WT)小鼠的雄性和雌性小鼠中获得的体感皮层神经元/神经胶质共培养物接种到六孔多电极阵列上。在培养第 4 天至第 14 天,每天进行 1 小时的电生理记录。在第 14 天给予 sTNFR1(0.0、0.3、3、30、60 和 120ng/µL)。在第 15 天进行最后 1 小时的记录。有四个指标被定义为用于体内睡眠的指标:动作电位(APs)、爆发指数(BI)、电活动同步性(SYN)和慢波功率(SWP;0.25-3.75Hz)。与 WT 小鼠相比,缺乏 TNF 或两种 TNFR 的小鼠来源的细胞中这些新出现的电生理特性的发育速度更快。在 TNFRKO 小鼠来源的细胞中,sTNFR1 的前三个较低剂量(0.3、3 和 30ng/µL)后 SWP 降低,表明处于类似觉醒状态。在 TNFKO 小鼠来源的细胞中,3ng/µl sTNFR1 处理后也诱导了类似觉醒的状态,因为它们表达 TNFR1 配体淋巴毒素α。WT 小鼠的细胞没有显示出治疗效果。这些结果与先前的研究一致,表明 TNF 参与了大脑发育、TNF 反向信号转导和体内睡眠调节。此外,目前在体外诱导 sTNFR1 产生类似觉醒状态的证明与这样的想法一致,即小的神经元/神经胶质回路表现出类似于体内发生的睡眠和觉醒状态。最后,sTNF 正向信号增强睡眠,而 sTNFR1 反向信号增强类似觉醒的状态,这与其他 sTNF/tmTNF/sTNFR1 脑作用具有相反的活性一致。